WCM Investment Management LLC Has $585.17 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

WCM Investment Management LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 1,189,761 shares of the medical equipment provider’s stock after acquiring an additional 3,099 shares during the quarter. Intuitive Surgical comprises about 1.5% of WCM Investment Management LLC’s portfolio, making the stock its 28th biggest holding. WCM Investment Management LLC’s holdings in Intuitive Surgical were worth $585,172,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Norges Bank acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $2,401,493,000. GAMMA Investing LLC lifted its stake in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares during the last quarter. Capital Research Global Investors grew its stake in shares of Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after buying an additional 687,906 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $313,769,000. Finally, Northern Trust Corp increased its holdings in Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider’s stock worth $1,889,126,000 after purchasing an additional 494,496 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president directly owned 5,224 shares of the company’s stock, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director directly owned 6,371 shares in the company, valued at $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 over the last ninety days. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on ISRG shares. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Thursday, June 5th. Truist Financial decreased their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Barclays reduced their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a “hold” rating to a “sell” rating and lowered their price objective for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Finally, Royal Bank Of Canada cut their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $588.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $537.99 on Wednesday. The stock has a fifty day moving average of $534.76 and a 200-day moving average of $536.73. The stock has a market cap of $192.83 billion, a PE ratio of 78.88, a price-to-earnings-growth ratio of 5.76 and a beta of 1.64. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the prior year, the company earned $1.50 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.